Fortis Healthcare Limited — Important, 07-02-2025: General Updates

**Updates:**

Fortis Healthcare Limited has experienced significant financial developments. In the recent board meeting, the company assessed its unaudited financial results for the quarter and half-year ending December 31, 2024. Key figures reveal a robust revenue from operations of ₹1,928.26 crore with a consolidated net profit of ₹254.30 crore during the quarter. Significant expenses include ₹450.74 crore allocated for medical consumables and drugs. The company has issued ₹1,550 crore worth of non-convertible debentures to fund strategic initiatives, further strengthening its financial position. Watch closely as operational improvements and strategic expansions could enhance growth and investor value.

**Investor Presentation:**

1. **Financial Highlights:** Fortis reported total income of ₹1,949.15 crore for the quarter, reflecting a year-on-year increase. The net profit stands at ₹254.30 crore, indicating strong operational efficiency.

2. **Strategic Initiatives and Growth Drivers:** The company aims to enhance its healthcare offerings, focusing on capacity building and technological integration to meet increasing healthcare demands.

3. **Business Developments:** Fortis allotted 1,55,000 non-convertible debentures valued at ₹1,00,000 each, totaling ₹1,550 crore, aimed at growth funding.

4. **Market Position and Competitive Advantage:** The firm maintains a solid market stance, leveraging a diverse portfolio and strategic partnerships to strengthen its position in the healthcare sector.

5. **Investor Implications:** The financial results suggest potential growth and enhanced shareholder value driven by strategic funding and operational excellence.

**Company Announcements:**

Fortis Healthcare Limited's board meeting resulted in the approval of key financial measures, including the issuance of ₹1,550 crore worth of non-convertible debentures. These debentures will support growth initiatives and fortify the company's financial standing. Moreover, the board also reviewed amendments to the company's Articles of Association to comply with regulatory requirements related to debenture trustee nominations. The strategic move positions Fortis for enhanced operational capacity, potentially benefiting shareholders.